주의력결핍과잉행동장애에서 Alpha-2A-Adrenergic 수용체 유전자와 Methylphenidate 반응과의 연관성에 대한 연구

키워드

참고문헌 (30)

1. Polanczyk G, "The worldwide prevalence of ADHD: a systematic review and metaregression analysis", Am J Psychiatry, 164, pp.942~948 (2007)
2. Wilens TE, "Effects of methylphenidate on the catecholaminergic system in attention-deficit", hyperactivity disorder, 2008, pp.28, 46~53
3. Spencer T, "Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle", J Am Acad Child Adolesc Psychiatry, 35, pp.409~432 (1996)
4. Berridge CW, "Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function", Biol Psychiatry, 60, pp.1111~1120 (2006)
5. Engert V, "Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate", Curr Neuropharmacol, 6, pp.322~328 (2008)
6. Arnsten AF, "Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder", Behav Brain Funct, 1, pp.2~ (2005)
7. Andrews GD, "Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors", Neuropsychopharmacology, 31, pp.594~601 (2006)
8. Ma CL, "Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys", Biol Psychiatry, 57, pp.192~195 (2005)
9. Ma CL, "Selective deficit in no-go performance induced by blockade of prefrontal cortical alpha 2-adrenoceptors in monkeys", Neuroreport, 14, pp.1013~1016 (2003)
10. Madras BK, "The dopamine transporter and attention-deficit", hyperactivity disorder, 2005, pp.57, 1397~1409
11. Arnsten AF, "Stimulants: Therapeutic actions in ADHD", Neuropsychopharmacology, 31, pp.2376~2383 (2006)
12. Arnsten AF, "The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder", Arch Gen Psychiatry, 53, pp.448~455 (1996)
13. Arnsten AF, "Catecholamine modulation of prefrontal cortical cognitive function", Trends Cogn Sci, 2, pp.436~447 (1998)
14. Jäkälä P, "Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans", Neuropsychopharmacology, 20, pp.119~130 (1999)
15. Lario S, "MspI identifies a biallelic polymorphism in the promoter region of the alpha 2Aadrenergic receptor gene", Clin Genet, 51, pp.129~130 (1997)
16. Hoehe MR, "Dra I identifies a two allele DNA polymorphism in the human alpha 2-adrenergic receptor gene (ADRAR), using a 5.5 kb probe (p ADRAR)", Nucleic Acids Res, 16, pp.9070~ (1988)
17. Cho SC, "Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder", AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 147B, pp.957~963 (2008), WILEY-LISS
18. Weinshilboum R, "Inheritance and drug response", N Engl J Med, 348, pp.529~537 (2003)
19. McGough JJ, "Attention-deficit", hyperactivity disorder pharmacogenomics, 2005, pp.57, 1367~1373
20. Polanczyk G, "Pharmacogenetic approach for a better drug treatment in children", Curr Pharm Des, 16, pp.2462~2473 (2010)
21. Polanczyk G, "Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit", hyperactivity disorder, 2007, pp.64, 218~224
22. da Silva TL, "Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit", hyperactivity disorder-predominantly inattentive type, 2008, pp.115, 341~345
23. Cheon KA, "Association Between Homozygosity of a G Allele of the Alpha-2a-Adrenergic Receptor Gene and Methylphenidate Response in Korean Children and Adolescents with Attention-Deficit", Hyperactivity Disorder, 2009, pp.65(7), 564~570
24. Contini V, "Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD", Eur Arch Psychiatry Clin Neurosci, 261, pp.205~211 (2011)
25. 김영신, "The Reliability and Validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean Version (K-SADS-PL-K)", Yonsei Medical Journal, 45(1), pp.81~89 (2004), 연세대학교의과대학
26. DuPaul GJ, "Parent and teacher ratings of ADHD symptoms: psychometric properties in a community-based sample", J Clin Child Psychol, 20, pp.245~253 (1991)
27. 소유경, "한국어판 부모, 교사 ADHD 평가 척도의 신뢰도와 타당도 연구", 신경정신의학, 41(2) (2002), 대한신경정신의학회
28. National Institute of Mental Health, "CGI, Clinical Global Impressions. In Manual of the ECDEU Assessment Battery, revised edition" (1970), Chevy Chase, Maryland: National Institute of Mental Health
29. Gizer IR, "Candidate gene studies of ADHD: a meta-analytic review", Hum Genet, 126, pp.51~90 (2009)
30. Lowe N, "An overview of the Pharmacogenetics and Molecular Genetics of ADHD", Curr Pharmocogenominc, 4, pp.231~243 (2006)

관련 논문AI추천